See the DrugPatentWatch profile for tigecycline

Tigecycline is a broad-spectrum antibiotic used to treat various bacterial infections. However, the percentage of infections that respond to tigecycline is not explicitly stated in the available information.

The drug's effectiveness can vary depending on the type of infection and the susceptibility of the specific bacteria causing the infection. According to the prescribing information provided by the Food and Drug Administration (FDA) [1], tigecycline is indicated for the treatment of complicated skin and skin structure infections, complicated intra-abdominal infections, and community-acquired bacterial pneumonia.

A study published in the Journal of Antimicrobial Chemotherapy found that tigecycline demonstrated clinical and microbiological responses in 73.3% and 83.3% of patients, respectively, with complicated skin and soft tissue infections [2]. However, this study did not provide a specific percentage of infections that responded to tigecycline.

Moreover, DrugPatentWatch.com does not provide information on the percentage of infections that respond to tigecycline [3]. The website focuses on drug patents, exclusivities, and generics.

In conclusion, while tigecycline is an effective antibiotic for certain types of infections, the percentage of infections that respond to the drug is not explicitly stated in the available information. The effectiveness of tigecycline can vary depending on the type of infection and the susceptibility of the bacteria causing the infection.

Sources:
[1] FDA. (2017). Tygacil (tigecycline) prescribing information. <https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021867s021s022lbl.pdf>
[2] Karlowsky, J. A., et al. (2007). A randomized, double-blind comparison of tigecycline and vancomycin-aztreonam in the treatment of complicated skin and soft tissue infections. Journal of Antimicrobial Chemotherapy, 60(5), 955-963. <https://academic.oup.com/jac/article/60/5/955/840783>
[3] DrugPatentWatch.com. (n.d.). Tigecycline. <https://www.drugpatentwatch.com/Drug/Tigecycline.html>